Nature Mental Health

Nature Mental Health is a peer-reviewed journal published by Springer Nature within the Nature Portfolio, launched in January 2023 as a multidisciplinary venue for research on mental health and the disorders of mental health, and it holds a 2025 Journal Impact Factor of 9.3《自然·心理健康》（Nature Mental Health）是施普林格·自然（Springer Nature）旗下自然科研（Nature Portfolio）出版的同行评审期刊，2023 年 1 月创刊，是以精神健康与精神障碍为对象的多学科研究平台，2025 年影响因子为 9.3。

Scope

• The journal publishes high-quality research and commentary across the breadth of mental health and the disorders of mental health该刊发表覆盖精神健康与精神障碍全领域的高质量研究与评论。
• It brings together investigation of the neurobiological and psychological factors that underpin psychiatric disorders该刊汇集对精神障碍神经生物学与心理学基础因素的探究。
• It examines the social determinants of health and the effects of public health crises on mental health该刊考察健康的社会决定因素以及公共卫生危机对心理健康的影响。
• Coverage spans psychiatry and psychology together with epidemiology, health economics and public policy其覆盖范围横跨精神病学与心理学，并及流行病学、卫生经济学与公共政策。
• Accepted work ranges from preclinical and translational studies to neuropharmacology, imaging and clinical treatment paradigms所接收工作涵盖从临床前与转化研究到神经药理学、影像学与临床治疗范式。
• Research across the lifespan is encouraged, with attention to underrepresented groups and globally understudied regions该刊鼓励贯穿全生命周期的研究，并关注代表性不足的群体与全球研究不足的地区。
• Content includes research articles, reviews, perspectives, comments and correspondence所刊内容含研究论文、综述、观点、评论与通讯。

History

• The journal was announced in March 2022 and launched in January 2023 as part of a Nature Portfolio expansion of three new titles该刊于 2022 年 3 月宣布创办、2023 年 1 月正式出版，是自然科研（Nature Portfolio）扩充三本新刊计划的一部分。
• It is published by Springer Nature and appears online-only each month under the electronic identifier 2731-6076该刊由施普林格·自然（Springer Nature）出版，纯在线发行，按月出版，电子刊号为 2731-6076。
• Rebecca Cooney was appointed founding Chief Editor in 2022 after serving as North American executive editor of The Lancet（Rebecca Cooney）于 2022 年获任创刊首席编辑，此前任（The Lancet）北美执行编辑。
• The journal is a transformative title that publishes by subscription while offering authors an open access option该刊为转换型期刊，以订阅方式出版并同时向作者提供开放获取选项。
• Its Journal Impact Factor moved from 8.7 in 2024 to 9.3 in 2025其影响因子由 2024 年的 8.7 升至 2025 年的 9.3。
• It is indexed in the Emerging Sources Citation Index and placed in the first quartile of the Psychiatry category该刊被（ESCI）收录，并在精神病学类位居第一四分位。

Editors

• Chief Editor Rebecca Cooney works on mood disorders, clinical trials and public health policy and has researched depression and anxiety首席编辑（Rebecca Cooney）从事心境障碍、临床试验与公共卫生政策研究，并曾研究抑郁与焦虑。
• The editorial team is distributed across New York, Berlin and London and retains roots in Latin America and Scandinavia编辑团队分布于纽约、柏林与伦敦，并保留拉丁美洲与斯堪的纳维亚的背景。
• The journal states an inclusive ethos and seeks authors and reviewers from underrepresented groups and emerging countries该刊宣示包容理念，寻求来自代表性不足群体与新兴国家的作者与审稿人。
• Manuscripts are submitted through the publisher's online system and are rigorously peer reviewed稿件经出版方在线系统投稿，并接受严格的同行评审。
• The journal is ranked 9th of 293 in the Psychiatry category and holds a 2025 Journal Impact Factor of 9.3该刊在精神病学类于 293 种刊中排名第 9，2025 年影响因子为 9.3。